{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T04:14:08Z","timestamp":1783397648139,"version":"3.54.6"},"reference-count":49,"publisher":"American Association for Cancer Research (AACR)","issue":"17","content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2007,9,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Epithelial tumorigenesis has been linked to AKT up-regulation. Human papillomaviruses (HPV) cause anogenital cancers and anogenital HPV infection up-regulates AKT activity. Mounting evidence points to a role for cutaneous HPVs as etiologic factors in skin tumorigenesis. High-risk cutaneous \u03b2 HPVs have been linked to carcinogenesis in immunosuppressed patients, and high-risk cutaneous HPV8 genes enhance tumorigenesis in transgenic mice. We find that, in contrast to anogenital HPVs, cutaneous HPV8 early genes down-regulate epidermal AKT activity by down-regulating AKT1 isoform levels. This down-regulation occurs before papilloma formation or tumorigenesis and leads to cutaneous differentiation changes that may weaken the epidermal squame for viral release. We find that, in viral warts (papillomas) and HPV gene-induced epidermal tumors, AKT activity can be activated focally by up-regulation and phosphorylation of the AKT2 isoform. In squamous cell carcinomas (SCC), AKT1 down-regulation is also common, consistent with a viral influence, whereas AKT2 up-regulation is widespread. Activation of up-regulated AKT2 by serine phosphorylation associates with high-grade tumors. Our data suggest that AKT2 up-regulation is characteristic of SCC and that coincident AKT2 activation through serine phosphorylation correlates with malignancy. These findings highlight differences between the effects of anogenital and cutaneous HPV on epithelial AKT activity and furthermore show that AKT isoforms can behave differently during epidermal tumorigenesis. These findings also suggest AKT2 as a possible therapeutic tumor target in SCC. [Cancer Res 2007;67(17):8207\u201315]<\/jats:p>","DOI":"10.1158\/0008-5472.can-07-0755","type":"journal-article","created":{"date-parts":[[2007,9,5]],"date-time":"2007-09-05T14:53:07Z","timestamp":1189003987000},"page":"8207-8215","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":38,"title":["Cutaneous Human Papillomaviruses Down-regulate AKT1, whereas AKT2 Up-regulation and Activation Associates with Tumors"],"prefix":"10.1158","volume":"67","author":[{"given":"Ryan F.L.","family":"O'Shaughnessy","sequence":"first","affiliation":[{"name":"1Institute of Cell and Molecular Science, Centre for Cutaneous Research and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baki","family":"Akgu\u0303l","sequence":"additional","affiliation":[{"name":"1Institute of Cell and Molecular Science, Centre for Cutaneous Research and"},{"name":"3Institute of Virology, University of Cologne, Cologne, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan","family":"Storey","sequence":"additional","affiliation":[{"name":"1Institute of Cell and Molecular Science, Centre for Cutaneous Research and"},{"name":"2Cancer Research UK Skin Tumour Laboratory, Barts and The London, Queen Mary School of Medicine and Dentistry, University of London, London, United Kingdom and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Herbert","family":"Pfister","sequence":"additional","affiliation":[{"name":"3Institute of Virology, University of Cologne, Cologne, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine A.","family":"Harwood","sequence":"additional","affiliation":[{"name":"1Institute of Cell and Molecular Science, Centre for Cutaneous Research and"},{"name":"2Cancer Research UK Skin Tumour Laboratory, Barts and The London, Queen Mary School of Medicine and Dentistry, University of London, London, United Kingdom and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolyn","family":"Byrne","sequence":"additional","affiliation":[{"name":"1Institute of Cell and Molecular Science, Centre for Cutaneous Research and"},{"name":"2Cancer Research UK Skin Tumour Laboratory, Barts and The London, Queen Mary School of Medicine and Dentistry, University of London, London, United Kingdom and"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1086","published-online":{"date-parts":[[2007,9,5]]},"reference":[{"key":"2022061623241535600_B1","doi-asserted-by":"crossref","unstructured":"Akgu\u0303l B, Cooke JC, Storey A. HPV-associated skin disease. J Pathol\u20082006; 208: 165\u201375.","DOI":"10.1002\/path.1893"},{"key":"2022061623241535600_B2","doi-asserted-by":"crossref","unstructured":"Schaper ID, Marcuzzi GP, Weissenborn SJ, et al. Development of skin tumors in mice transgenic for early genes of human papillomavirus type 8. Cancer Res\u20082005; 65: 1394\u2013400.","DOI":"10.1158\/0008-5472.CAN-04-3263"},{"key":"2022061623241535600_B3","doi-asserted-by":"crossref","unstructured":"Pim D, Massimi P, Dilworth SM, Banks L. Activation of the protein kinase B pathway by the HPV-16 E7 oncoprotein occurs through a mechanism involving interaction with PP2A. Oncogene\u20082005; 24: 7830\u20138.","DOI":"10.1038\/sj.onc.1208935"},{"key":"2022061623241535600_B4","doi-asserted-by":"crossref","unstructured":"Menges CW, Baglia LA, Lapoint R, McCance DJ. Human papillomavirus type 16 E7 up-regulates AKT activity through the retinoblastoma protein. Cancer Res\u20082006; 66: 5555\u20139.","DOI":"10.1158\/0008-5472.CAN-06-0499"},{"key":"2022061623241535600_B5","doi-asserted-by":"crossref","unstructured":"Woodgett JR. Recent advances in the protein kinase B signaling pathway. Curr Opin Cell Biol\u20082005; 17: 150\u20137.","DOI":"10.1016\/j.ceb.2005.02.010"},{"key":"2022061623241535600_B6","doi-asserted-by":"crossref","unstructured":"Peng XD, Xu PZ, Chen ML, et al. Dwarfism, impaired skin development, skeletal muscle atrophy, delayed bone development, and impeded adipogenesis in mice lacking Akt1 and Akt2. Genes Dev\u20082003; 17: 1352\u201365.","DOI":"10.1101\/gad.1089403"},{"key":"2022061623241535600_B7","doi-asserted-by":"crossref","unstructured":"Cho H, Mu J, Kim JK, et al. Insulin resistance and a diabetes mellitus-like syndrome in mice lacking the protein kinase Akt2 (PKB\u03b2). Science\u20082001; 292: 1728\u201331.","DOI":"10.1126\/science.292.5522.1728"},{"key":"2022061623241535600_B8","doi-asserted-by":"crossref","unstructured":"Cho H, Thorvaldsen JL, Chu Q, Feng F, Birnbaum MJ. Akt1\/PKB\u03b1 is required for normal growth but dispensable for maintenance of glucose homeostasis in mice. J Biol Chem\u20082001; 276: 38349\u201352.","DOI":"10.1074\/jbc.C100462200"},{"key":"2022061623241535600_B9","doi-asserted-by":"crossref","unstructured":"Heron-Milhavet L, Franckhauser C, Rana V, et al. Only Akt1 is required for proliferation, while Akt2 promotes cell cycle exit through p21 binding. Mol Cell Biol\u20082006; 26: 8267\u201380.","DOI":"10.1128\/MCB.00201-06"},{"key":"2022061623241535600_B10","doi-asserted-by":"crossref","unstructured":"Irie HY, Pearline RV, Grueneberg D, et al. Distinct roles of Akt1 and Akt2 in regulating cell migration and epithelial-mesenchymal transition. J Cell Biol\u20082005; 171: 1023\u201334.","DOI":"10.1083\/jcb.200505087"},{"key":"2022061623241535600_B11","doi-asserted-by":"crossref","unstructured":"Altomare DA, Tanno S, De Rienzo A, et al. Frequent activation of AKT2 kinase in human pancreatic carcinomas. J Cell Biochem\u20082003; 88: 470\u20136.","DOI":"10.1002\/jcb.10287"},{"key":"2022061623241535600_B12","doi-asserted-by":"crossref","unstructured":"Toker A, Yoeli-Lerner M. Akt signaling and cancer: surviving but not moving on. Cancer Res\u20082006; 66: 3963\u20136.","DOI":"10.1158\/0008-5472.CAN-06-0743"},{"key":"2022061623241535600_B13","doi-asserted-by":"crossref","unstructured":"Segrelles C, Ruiz S, Perez P, et al. Functional roles of Akt signaling in mouse skin tumorigenesis. Oncogene\u20082002; 21: 53\u201364.","DOI":"10.1038\/sj.onc.1205032"},{"key":"2022061623241535600_B14","doi-asserted-by":"crossref","unstructured":"Mao JH, To MD, Perez-Losada J, Wu D, Del Rosario R, Balmain A. Mutually exclusive mutations of the Pten and ras pathways in skin tumor progression. Genes Dev\u20082004; 18: 1800\u20135.","DOI":"10.1101\/gad.1213804"},{"key":"2022061623241535600_B15","doi-asserted-by":"crossref","unstructured":"Thrash BR, Menges CW, Pierce RH, McCance DJ. AKT1 provides an essential survival signal required for differentiation and stratification of primary human keratinocytes. J Biol Chem\u20082006; 281: 12155\u201362.","DOI":"10.1074\/jbc.M512116200"},{"key":"2022061623241535600_B16","doi-asserted-by":"crossref","unstructured":"Janes SM, Ofstad TA, Campbell DH, Watt FM, Prowse DM. Transient activation of FOXN1 in keratinocytes induces a transcriptional programme that promotes terminal differentiation: contrasting roles of FOXN1 and Akt. J Cell Sci\u20082004; 117: 4157\u201368.","DOI":"10.1242\/jcs.01302"},{"key":"2022061623241535600_B17","doi-asserted-by":"crossref","unstructured":"Calautti E, Li J, Saoncella S, Brissette JL, Goetinck PF. Phosphoinositide 3-kinase signaling to Akt promotes keratinocyte differentiation versus death. J Biol Chem\u20082005; 280: 32856\u201365.","DOI":"10.1074\/jbc.M506119200"},{"key":"2022061623241535600_B18","doi-asserted-by":"crossref","unstructured":"O'Shaughnessy RF, Welti JC, Cooke JC, et al. AKT-dependent HspB1 (Hsp27) activity in epidermal development. J Biol Chem\u20082007; 282: 17297\u2013305.","DOI":"10.1074\/jbc.M610386200"},{"key":"2022061623241535600_B19","doi-asserted-by":"crossref","unstructured":"Candi E, Schmidt R, Melino G. The cornified envelope: a model of cell death in the skin. Nat Rev Mol Cell Biol\u20082005; 6: 328\u201340.","DOI":"10.1038\/nrm1619"},{"key":"2022061623241535600_B20","doi-asserted-by":"crossref","unstructured":"Lehr E, Jarnik M, Brown DR. Human papillomavirus type 11 alters the transcription and expression of loricrin, the major cell envelope protein. Virology\u20082002; 298: 240\u20137.","DOI":"10.1006\/viro.2002.1445"},{"key":"2022061623241535600_B21","doi-asserted-by":"crossref","unstructured":"Lehr E, Brown DR. Infection with the oncogenic human papillomavirus type 59 alters protein components of the cornified cell envelope. Virology\u20082003; 309: 53\u201360.","DOI":"10.1016\/S0042-6822(02)00100-9"},{"key":"2022061623241535600_B22","doi-asserted-by":"crossref","unstructured":"Komuves LG, Hanley K, Jiang Y, Elias PM, Williams ML, Feingold KR. Ligands and activators of nuclear hormone receptors regulate epidermal differentiation during fetal rat skin development. J Invest Dermatol\u20081998; 111: 429\u201333.","DOI":"10.1046\/j.1523-1747.1998.00296.x"},{"key":"2022061623241535600_B23","doi-asserted-by":"crossref","unstructured":"Akgu\u0303l B, Garcia-Escudero R, Ghali L, et al. The E7 protein of cutaneous human papillomavirus type 8 causes invasion of human keratinocytes into the dermis in organotypic cultures of skin. Cancer Res\u20082005; 65: 2216\u201323.","DOI":"10.1158\/0008-5472.CAN-04-1952"},{"key":"2022061623241535600_B24","doi-asserted-by":"crossref","unstructured":"Leverrier S, Bergamaschi D, Ghali L, et al. Role of HPV E6 proteins in preventing UVB-induced release of pro-apoptotic factors from the mitochondria. Apoptosis\u20082007; 12: 549\u201360.","DOI":"10.1007\/s10495-006-0004-1"},{"key":"2022061623241535600_B25","doi-asserted-by":"crossref","unstructured":"Zhang H, Zha X, Tan Y, et al. Phosphoprotein analysis using antibodies broadly reactive against phosphorylated motifs. J Biol Chem\u20082002; 277: 39379\u201387.","DOI":"10.1074\/jbc.M206399200"},{"key":"2022061623241535600_B26","doi-asserted-by":"crossref","unstructured":"Hewett DR, Simons AL, Mangan NE, et al. Lethal, neonatal ichthyosis with increased proteolytic processing of filaggrin in a mouse model of Netherton syndrome. Hum Mol Genet\u20082005; 14: 335\u201346.","DOI":"10.1093\/hmg\/ddi030"},{"key":"2022061623241535600_B27","doi-asserted-by":"crossref","unstructured":"Wang Q, Griffin H, Southern S, et al. Functional analysis of the human papillomavirus type 16 E1^E4 protein provides a mechanism for in vivo and in vitro keratin filament reorganization. J Virol\u20082004; 78: 821\u201333.","DOI":"10.1128\/JVI.78.2.821-833.2004"},{"key":"2022061623241535600_B28","doi-asserted-by":"crossref","unstructured":"Roberts S, Ashmole I, Johnson GD, Kreider JW, Gallimore PH. Cutaneous and mucosal human papillomavirus E4 proteins form intermediate filament-like structures in epithelial cells. Virology\u20081993; 197: 176\u201387.","DOI":"10.1006\/viro.1993.1578"},{"key":"2022061623241535600_B29","doi-asserted-by":"crossref","unstructured":"Steger G, Schnabel C, Schmidt HM. The hinge region of the human papillomavirus type 8 E2 protein activates the human p21(WAF1\/CIP1) promoter via interaction with Sp1. J Gen Virol\u20082002; 83: 503\u201310.","DOI":"10.1099\/0022-1317-83-3-503"},{"key":"2022061623241535600_B30","doi-asserted-by":"crossref","unstructured":"Hadaschik D, Hinterkeuser K, Oldak M, Pfister HJ, Smola-Hess S. The papillomavirus E2 protein binds to and synergizes with C\/EBP factors involved in keratinocyte differentiation. J Virol\u20082003; 77: 5253\u201365.","DOI":"10.1128\/JVI.77.9.5253-5265.2003"},{"key":"2022061623241535600_B31","doi-asserted-by":"crossref","unstructured":"Haller K, Stubenrauch F, Pfister H. Differentiation-dependent transcription of the epidermodysplasia verruciformis-associated human papillomavirus type 5 in benign lesions. Virology\u20081995; 214: 245\u201355.","DOI":"10.1006\/viro.1995.0028"},{"key":"2022061623241535600_B32","doi-asserted-by":"crossref","unstructured":"Forslund O, Lindelof B, Hradil E, et al. High prevalence of cutaneous human papillomavirus DNA on the top of skin tumors but not in \u201cstripped\u201d biopsies from the same tumors. J Invest Dermatol\u20082004; 123: 388\u201394.","DOI":"10.1111\/j.0022-202X.2004.23205.x"},{"key":"2022061623241535600_B33","unstructured":"Elder JT. Warts and skin cancer: only skin deep? J Invest Dermatol\u20082004; 123i: vi."},{"key":"2022061623241535600_B34","doi-asserted-by":"crossref","unstructured":"Orth G. Human papillomaviruses and the skin: more to be learned. J Invest Dermatol\u20082004; 123: XI\u2013XIII.","DOI":"10.1111\/j.0022-202X.2004.23243.x"},{"key":"2022061623241535600_B35","doi-asserted-by":"crossref","unstructured":"Yoeli-Lerner M, Yiu GK, Rabinovitz I, Erhardt P, Jauliac S, Toker A. Akt blocks breast cancer cell motility and invasion through the transcription factor NFAT. Mol Cell\u20082005; 20: 539\u201350.","DOI":"10.1016\/j.molcel.2005.10.033"},{"key":"2022061623241535600_B36","unstructured":"Grille SJ, Bellacosa A, Upson J, et al. The protein kinase Akt induces epithelial mesenchymal transition and promotes enhanced motility and invasiveness of squamous cell carcinoma lines. Cancer Res\u20082003; 63: 2172\u20138."},{"key":"2022061623241535600_B37","doi-asserted-by":"crossref","unstructured":"Staal SP. Molecular cloning of the akt oncogene and its human homologues AKT1 and AKT2: amplification of AKT1 in a primary human gastric adenocarcinoma. Proc Natl Acad Sci U S A\u20081987; 84: 5034\u20137.","DOI":"10.1073\/pnas.84.14.5034"},{"key":"2022061623241535600_B38","doi-asserted-by":"crossref","unstructured":"Sun M, Wang G, Paciga JE, et al. AKT1\/PKB\u03b1 kinase is frequently elevated in human cancers and its constitutive activation is required for oncogenic transformation in NIH3T3 cells. Am J Pathol\u20082001; 159: 431\u20137.","DOI":"10.1016\/S0002-9440(10)61714-2"},{"key":"2022061623241535600_B39","doi-asserted-by":"crossref","unstructured":"Miwa W, Yasuda J, Murakami Y, et al. Isolation of DNA sequences amplified at chromosome 19q13.1-q13.2 including the AKT2 locus in human pancreatic cancer. Biochem Biophys Res Commun\u20081996; 225: 968\u201374.","DOI":"10.1006\/bbrc.1996.1280"},{"key":"2022061623241535600_B40","doi-asserted-by":"crossref","unstructured":"Ruggeri BA, Huang L, Wood M, Cheng JQ, Testa JR. Amplification and overexpression of the AKT2 oncogene in a subset of human pancreatic ductal adenocarcinomas. Mol Carcinog\u20081998; 21: 81\u20136.","DOI":"10.1002\/(SICI)1098-2744(199802)21:2<81::AID-MC1>3.0.CO;2-R"},{"key":"2022061623241535600_B41","doi-asserted-by":"crossref","unstructured":"Yuan ZQ, Sun M, Feldman RI, et al. Frequent activation of AKT2 and induction of apoptosis by inhibition of phosphoinositide-3-OH kinase\/Akt pathway in human ovarian cancer. Oncogene\u20082000; 19: 2324\u201330.","DOI":"10.1038\/sj.onc.1203598"},{"key":"2022061623241535600_B42","doi-asserted-by":"crossref","unstructured":"Bellacosa A, de Feo D, Godwin AK, et al. Molecular alterations of the AKT2 oncogene in ovarian and breast carcinomas. Int J Cancer\u20081995; 64: 280\u20135.","DOI":"10.1002\/ijc.2910640412"},{"key":"2022061623241535600_B43","doi-asserted-by":"crossref","unstructured":"Bacus SS, Altomare DA, Lyass L, et al. AKT2 is frequently upregulated in HER-2\/neu-positive breast cancers and may contribute to tumor aggressiveness by enhancing cell survival. Oncogene\u20082002; 21: 3532\u201340.","DOI":"10.1038\/sj.onc.1205438"},{"key":"2022061623241535600_B44","doi-asserted-by":"crossref","unstructured":"Cheng GZ, Chan J, Wang Q, Zhang W, Sun CD, Wang LH. Twist transcriptionally up-regulates AKT2 in breast cancer cells leading to increased migration, invasion, and resistance to paclitaxel. Cancer Res\u20082007; 67: 1979\u201387.","DOI":"10.1158\/0008-5472.CAN-06-1479"},{"key":"2022061623241535600_B45","doi-asserted-by":"crossref","unstructured":"Roy HK, Olusola BF, Clemens DL, et al. AKT proto-oncogene overexpression is an early event during sporadic colon carcinogenesis. Carcinogenesis\u20082002; 23: 201\u20135.","DOI":"10.1093\/carcin\/23.1.201"},{"key":"2022061623241535600_B46","doi-asserted-by":"crossref","unstructured":"Parsons DW, Wang TL, Samuels Y, et al. Colorectal cancer: mutations in a signalling pathway. Nature\u20082005; 436: 792.","DOI":"10.1038\/436792a"},{"key":"2022061623241535600_B47","doi-asserted-by":"crossref","unstructured":"Xu X, Sakon M, Nagano H, et al. Akt2 expression correlates with prognosis of human hepatocellular carcinoma. Oncol Rep\u20082004; 11: 25\u201332.","DOI":"10.3892\/or.11.1.25"},{"key":"2022061623241535600_B48","doi-asserted-by":"crossref","unstructured":"Altomare DA, Testa JR. Perturbations of the AKT signaling pathway in human cancer. Oncogene\u20082005; 24: 7455\u201364.","DOI":"10.1038\/sj.onc.1209085"},{"key":"2022061623241535600_B49","doi-asserted-by":"crossref","unstructured":"Cheng JQ, Lindsley CW, Cheng GZ, Yang H, Nicosia SV. The Akt\/PKB pathway: molecular target for cancer drug discovery. Oncogene\u20082005; 24: 7482\u201392.","DOI":"10.1038\/sj.onc.1209088"}],"container-title":["Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/67\/17\/8207\/2573064\/8207.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/67\/17\/8207\/2573064\/8207.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,16]],"date-time":"2022-06-16T23:33:33Z","timestamp":1655422413000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerres\/article\/67\/17\/8207\/533465\/Cutaneous-Human-Papillomaviruses-Down-regulate"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,9,1]]},"references-count":49,"journal-issue":{"issue":"17","published-online":{"date-parts":[[2007,9,5]]},"published-print":{"date-parts":[[2007,9,1]]}},"URL":"https:\/\/doi.org\/10.1158\/0008-5472.can-07-0755","relation":{"is-supplemented-by":[{"id-type":"doi","id":"10.1158\/0008-5472.22367591.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22367588","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22367594.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22367594","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22367591","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22367588.v1","asserted-by":"object"}],"has-preprint":[{"id-type":"doi","id":"10.1158\/0008-5472.c.6495617.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.c.6495617","asserted-by":"object"}]},"ISSN":["0008-5472","1538-7445"],"issn-type":[{"value":"0008-5472","type":"print"},{"value":"1538-7445","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,9,1]]}}}